daunorubicin has been researched along with Retinal Diseases in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (46.67) | 18.7374 |
| 1990's | 8 (53.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kirmani, M; Minckler, DS; Patterson, R; Ryan, SJ; Santana, M; Sorgente, N; Wiedemann, P | 1 |
| Chen, EP; Hatchell, DL; Machemer, R; Steinhorst, UH | 1 |
| Cai, YS; Heimann, K; Hui, YN; Kirchhof, B; Liang, HC | 1 |
| Fammartino, JJ; Oh, KT | 1 |
| Chen, EP; Hatchell, DL; Saloupis, PT; Samsa, GP; Steinhorst, UH | 1 |
| Hatchell, DL; Khawly, JA; Machemer, R; Saloupis, P | 1 |
| Heimann, K; Hilgers, RD; Leinung, C; Wiedemann, P | 1 |
| Heimann, K; Wiedemann, P | 2 |
| Brown, CS; Heath, TD; Stern, WH | 1 |
| Evans, PY; Heimann, K; Meyer-Schwickerath, R; Wiedemann, P; Wiedemann, R | 1 |
| Dalma-Weizhausz, J; Orr, GM; Renardel de Lavalette, VW; Ryan, SJ; Sorgente, N; Verdoorn, C | 1 |
| Heimann, K; Lemmen, KD; Moter, H; Wiedemann, P; Wiedemann, R | 1 |
| Heimann, K; Lemmen, K; Schmiedl, R; Wiedemann, P | 1 |
| Bekhor, C; Patterson, R; Ryan, SJ; Sorgente, N; Tran, T; Wiedemann, P | 1 |
2 trial(s) available for daunorubicin and Retinal Diseases
| Article | Year |
|---|---|
A fluorescein angiographic study on patients with proliferative vitreoretinopathy treated by vitrectomy and intraocular daunomycin.
Topics: Adult; Aged; Choroid; Daunorubicin; Female; Fluorescein Angiography; Humans; Macular Edema; Male; Middle Aged; Photography; Pigment Epithelium of Eye; Retinal Diseases; Silicone Oils; Uveal Diseases; Visual Acuity; Vitrectomy | 1989 |
[A randomized, prospective study of the treatment of proliferative vitreoretinopathy with daunomycin].
Topics: Clinical Trials as Topic; Combined Modality Therapy; Daunorubicin; Female; Humans; Male; Middle Aged; Prospective Studies; Random Allocation; Retinal Diseases; Silicone Oils; Vitrectomy | 1988 |
13 other study(ies) available for daunorubicin and Retinal Diseases
| Article | Year |
|---|---|
Daunomycin in the treatment of experimental proliferative vitreoretinopathy: retinal toxicity of intravitreal daunomycin in the rabbit.
Topics: Animals; Daunorubicin; Electroretinography; Eye Diseases; Female; Injections; Male; Microscopy, Electron; Rabbits; Retina; Retinal Diseases; Vitreous Body | 1984 |
Ocular toxicity of daunomycin: effects of subdivided doses on the rabbit retina after vitreous gas compression.
Topics: Animals; Dark Adaptation; Daunorubicin; Electroretinography; Eye Diseases; Female; Fluorocarbons; Male; Rabbits; Retinal Diseases; Vitreous Body | 1993 |
Corticosteroids and daunomycin in the prevention of experimental proliferative vitreoretinopathy induced by macrophages.
Topics: Animals; Daunorubicin; Disease Models, Animal; Drug Carriers; Eye Diseases; Female; Injections; Liposomes; Macrophages; Male; Rabbits; Retinal Detachment; Retinal Diseases; Triamcinolone Acetonide; Vitreous Body | 1993 |
Epiretinal membrane formation.
Topics: Aged; Antibiotics, Antineoplastic; Cell Division; Daunorubicin; Female; Humans; Male; Membranes; Recurrence; Retinal Diseases; Visual Acuity; Vitrectomy | 1996 |
The effect of combined daunorubicin and triamcinolone acetonide treatment on a refined experimental model of proliferative vitreoretinopathy.
Topics: Animals; Daunorubicin; Disease Models, Animal; Drug Therapy, Combination; Eye Diseases; Female; Fibroblasts; Fundus Oculi; Male; Rabbits; Random Allocation; Retinal Detachment; Retinal Diseases; Triamcinolone Acetonide; Vitreous Body | 1992 |
Daunorubicin treatment in a refined experimental model of proliferative vitreoretinopathy.
Topics: Animals; Cell Division; Daunorubicin; Disease Models, Animal; Drug Administration Schedule; Eye Diseases; Fibroblasts; Rabbits; Random Allocation; Retinal Detachment; Retinal Diseases; Vitreous Body | 1991 |
Daunomycin and silicone oil for the treatment of proliferative vitreoretinopathy.
Topics: Daunorubicin; Eye Diseases; Follow-Up Studies; Humans; Longitudinal Studies; Reoperation; Retinal Detachment; Retinal Diseases; Silicone Oils; Visual Acuity; Vitrectomy; Vitreous Body | 1991 |
Toxicity of intraocular daunomycin.
Topics: Daunorubicin; Fluorescein Angiography; Humans; Perfusion; Retinal Diseases; Silicone Oils; Visual Acuity; Visual Fields; Vitrectomy | 1990 |
Ocular cicatricial disease. Drug effects in vitro on cell proliferation, contraction, and viability.
Topics: Animals; Cell Division; Cell Survival; Cells, Cultured; Cicatrix; Dactinomycin; Daunorubicin; Orotic Acid; Rabbits; Retinal Diseases; Skin; Tunicamycin | 1990 |
Cellular migration, proliferation, and contraction. An in vitro approach to a clinical problem--proliferative vitreoretinopathy.
Topics: Alkaloids; Animals; Cell Division; Cells, Cultured; Chemotaxis; Colchicine; Cytochalasin B; Daunorubicin; Fibroblasts; Paclitaxel; Rabbits; Retina; Retinal Diseases; Skin | 1986 |
Intraocular daunorubicin for the treatment and prophylaxis of traumatic proliferative vitreoretinopathy.
Topics: Daunorubicin; Eye Diseases; Eye Injuries; Humans; Retinal Diseases; Visual Acuity; Vitreous Body | 1987 |
[Proliferative vitreoretinopathy. Pathogenesis and possibilities for treatment with cytostatic drugs].
Topics: Antineoplastic Agents; Cell Division; Daunorubicin; Eye Diseases; Fluorouracil; Humans; Pigment Epithelium of Eye; Pyrimidines; Retinal Diseases; Vitreous Body | 1986 |
Daunomycin in the treatment of experimental proliferative vitreoretinopathy. Effective doses in vitro and in vivo.
Topics: Animals; Autoradiography; Chromatography, High Pressure Liquid; Daunorubicin; Eye Diseases; Fibroblasts; In Vitro Techniques; Rabbits; Retinal Diseases; Spectrometry, Fluorescence; Vitreous Body | 1985 |